Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001376474-26-000232·CERO THERAPEUTICS HOLDINGS, INC.
Schedule 13G ownership disclosure
CERO THERAPEUTICS HOLDINGS, INC.
Common Stock · CUSIP: 15687V102
Event date: 2026-02-19
- Filing-level shares
- 1,830,007
- Percent of class
- 8.67%
- Tibbs Isaiah
Shares: 1,830,007 · Class: 8.67%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001376474-26-000232
- Form type
- SCHEDULE 13G
- Filer
- CERO THERAPEUTICS HOLDINGS, INC.
- CIK
- CIK 1870404
- Filed
- Mar 12, 2026
- Reporting period
- Feb 19, 2026
- Description
- Schedule 13G beneficial ownership